Skip to main content
Clinical Trials/KCT0008336
KCT0008336
Not yet recruiting
未知

The efficacy and safety of clonal mesenchymal stem cell therapy for Hutchinson-Gilford Progeria syndrome

Inha University Hospital0 sites1 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Endocrine, nutritional and metabolic diseases
Sponsor
Inha University Hospital
Enrollment
1
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Genetically confirmed Hutchinson\-Gilford progeria syndrome (progeria in childhood)
  • 2\. Typical clinical symptoms of progeria identified by medical staff in this clinical study
  • 3\. Aspartate aminotransferase (AST) and alanine aminotransfers (ALT) at the time of enrollment/screening \< 5× upper limit of normal
  • 4\. Research subjects and legal representatives who must be able to visit the center according to this research plan and who are willing to participate voluntarily

Exclusion Criteria

  • Research subjects who fall under any of the following are excluded from the study.
  • 1\. Severe renal impairment (GFR \< 30ml/min/1\.73m2\)
  • 2\. Other clinical study medications received 90 days prior to the first treatment visit
  • 3\.Persons with serious adverse reactions during stem cell treatmen
  • 4\. In the case of a medical condition that prevents safe participation in the study according to the opinion of the research director

Outcomes

Primary Outcomes

Not specified

Similar Trials